{"id":"https://openalex.org/W15207001","doi":null,"title":"Do cholinesterase inhibitors slow progression of Alzheimer's disease?","display_name":"Do cholinesterase inhibitors slow progression of Alzheimer's disease?","publication_year":2002,"publication_date":"2002-06-01","ids":{"openalex":"https://openalex.org/W15207001","mag":"15207001","pmid":"https://pubmed.ncbi.nlm.nih.gov/12139366"},"language":"en","primary_location":{"id":"pmid:12139366","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12139366","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of clinical practice. Supplement","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071364728","display_name":"Martin Rhys Farlow","orcid":"https://orcid.org/0000-0001-7897-5471","observed_orcids":["https://orcid.org/0000-0001-7897-5471"]},"institutions":[{"id":"https://openalex.org/I4394709130","display_name":"Indiana University School of Medicine","ror":"https://ror.org/02ets8c94","country_code":"US","type":"education","lineage":["https://openalex.org/I4394709130","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"M R Farlow","raw_affiliation_strings":["Indiana University School of Medicine, Indianapolis, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Indiana University School of Medicine, Indianapolis, USA","institution_ids":["https://openalex.org/I4394709130"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5071364728"],"corresponding_institution_ids":["https://openalex.org/I4394709130"],"apc_list":null,"apc_paid":null,"fwci":2.105,"has_fulltext":false,"cited_by_count":42,"citation_normalized_percentile":{"value":0.85975847,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":null,"issue":"127","first_page":"37","last_page":"44"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.7515000104904175,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.7515000104904175,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.14669999480247498,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.09910000115633011,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9789999723434448},{"id":"https://openalex.org/keywords/rivastigmine","display_name":"rivastigmine","score":0.9300000071525574},{"id":"https://openalex.org/keywords/cholinesterase-inhibitors","display_name":"cholinesterase inhibitors","score":0.9860000014305115},{"id":"https://openalex.org/keywords/disease-progression","display_name":"disease progression","score":0.8349999785423279},{"id":"https://openalex.org/keywords/disease-modifying-therapy","display_name":"disease-modifying therapy","score":0.6899999976158142},{"id":"https://openalex.org/keywords/acetylcholinesterase","display_name":"acetylcholinesterase","score":0.8690000176429749},{"id":"https://openalex.org/keywords/butyrylcholinesterase","display_name":"butyrylcholinesterase","score":0.9879999756813049},{"id":"https://openalex.org/keywords/amyloid-plaques","display_name":"amyloid plaques","score":0.871999979019165},{"id":"https://openalex.org/keywords/neuritic-plaques","display_name":"neuritic plaques","score":0.8659999966621399},{"id":"https://openalex.org/keywords/cognitive-outcomes","display_name":"cognitive outcomes","score":0.6499999761581421},{"id":"https://openalex.org/keywords/behavioural-symptoms","display_name":"behavioural symptoms","score":0.8080000281333923},{"id":"https://openalex.org/keywords/long-term-treatment-outcomes","display_name":"long-term treatment outcomes","score":0.5740000009536743}],"concepts":[{"id":"https://openalex.org/C2776332859","wikidata":"https://www.wikidata.org/wiki/Q411887","display_name":"Rivastigmine","level":5,"score":0.9901220202445984},{"id":"https://openalex.org/C2779056891","wikidata":"https://www.wikidata.org/wiki/Q412690","display_name":"Galantamine","level":5,"score":0.7342231869697571},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.731620728969574},{"id":"https://openalex.org/C2778816929","wikidata":"https://www.wikidata.org/wiki/Q22676679","display_name":"Acetylcholinesterase","level":3,"score":0.7284716367721558},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6382222175598145},{"id":"https://openalex.org/C31896038","wikidata":"https://www.wikidata.org/wiki/Q415635","display_name":"Cholinesterase","level":2,"score":0.6286075711250305},{"id":"https://openalex.org/C2779101902","wikidata":"https://www.wikidata.org/wiki/Q22679015","display_name":"Butyrylcholinesterase","level":5,"score":0.5958752036094666},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5107944011688232},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5075856447219849},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.4932560324668884},{"id":"https://openalex.org/C502032728","wikidata":"https://www.wikidata.org/wiki/Q11081","display_name":"Alzheimer's disease","level":3,"score":0.42338281869888306},{"id":"https://openalex.org/C2780904820","wikidata":"https://www.wikidata.org/wiki/Q415081","display_name":"Donepezil","level":4,"score":0.39308011531829834},{"id":"https://openalex.org/C2779059548","wikidata":"https://www.wikidata.org/wiki/Q383701","display_name":"Ach\u00e9","level":4,"score":0.22059091925621033},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.17125046253204346},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.06487628817558289},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000068836","descriptor_name":"Rivastigmine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002219","descriptor_name":"Carbamates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002800","descriptor_name":"Cholinesterase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018697","descriptor_name":"Nootropic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D048448","descriptor_name":"Phenylcarbamates","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:12139366","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12139366","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of clinical practice. Supplement","raw_type":"Journal Article"},{"id":"mag:15207001","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12139366","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1978342865","https://openalex.org/W2297671054","https://openalex.org/W2411273853","https://openalex.org/W2138135118","https://openalex.org/W2080291833","https://openalex.org/W2089223747","https://openalex.org/W2074232386","https://openalex.org/W2119619136","https://openalex.org/W4248501536","https://openalex.org/W2070059663"],"abstract_inverted_index":{"In":[0,93],"the":[1,24,58,79,133,147,155,160,178,186,205,273],"absence":[2],"of":[3,23,47,61,81,97,108,182,188,207,227,250,259,277],"a":[4,43,217],"cure":[5],"for":[6,33,57,132,146,154,234,266,279,292],"Alzheimer's":[7],"disease":[8,67,189],"(AD),":[9],"treatment":[10,106,164],"has":[11],"focused":[12],"on":[13,110,229],"therapy":[14],"to":[15,20,77,86,102,263,289],"provide":[16,64],"symptomatic":[17,65],"benefits":[18,181,240,249],"and":[19,51,66,112,127,199,215,269],"slow":[21,78,284],"progression":[22,68,206],"disease,":[25,175],"so":[26],"that":[27,41,53,177,204,216],"patients":[28,128,171,196,214,260,271,288],"can":[29],"maintain":[30,290],"their":[31],"independence":[32],"as":[34,36],"long":[35],"possible.":[37],"New":[38],"research":[39],"suggests":[40],"rivastigmine,":[42],"potent,":[44],"pseudo-irreversible":[45],"inhibitor":[46],"both":[48],"acetylcholinesterase":[49],"(AChE)":[50],"butyrylcholinesterase":[52],"shows":[54],"preferential":[55],"selectivity":[56],"G1":[59],"form":[60],"AChE,":[62],"may":[63,75,220,283],"slowing":[69],"effects.":[70],"The":[71,191,225,247],"drug's":[72],"pharmacological":[73],"properties":[74],"help":[76],"conversion":[80],"diffuse,":[82],"benign":[83],"amyloid":[84],"plaques":[85,88],"neuritic":[87],"associated":[89],"with":[90,172,197,239,261,272],"clinical":[91],"dementia.":[92],"'delayed-start'":[94],"paradigms--open-label":[95],"extensions":[96],"placebo-controlled":[98,161],"studies":[99],"involving":[100],"mild":[101,198,262],"moderate":[103,264],"AD":[104,202,208,265,278,285],"patients--the":[105],"effects":[107,165,226],"rivastigmine":[109,131,144,183,228,251],"cognitive":[111],"non-cognitive":[113],"outcomes":[114,139],"at":[115,124,235],"52":[116,135],"weeks":[117,136,150,158,268],"were":[118,166],"even":[119,167],"greater":[120],"than":[121,140],"those":[122,141,195],"observed":[123],"26":[125,149,157],"weeks,":[126],"who":[129,142],"received":[130,143,152],"entire":[134],"had":[137],"better":[138],"only":[145],"latter":[148],"(having":[151],"placebo":[153,243],"first":[156],"during":[159],"phase).":[162],"These":[163],"more":[168],"robust":[169],"in":[170,194,212,256,270],"moderately":[173,200],"severe":[174,201],"indicating":[176],"sustained":[179],"long-term":[180,248],"apply":[184],"across":[185],"continuum":[187],"severity.":[190],"results":[192],"seen":[193],"suggest":[203],"was":[209],"being":[210],"slowed":[211],"treated":[213],"disease-modifying":[218],"effect":[219],"have":[221,252],"been":[222,254],"taking":[223],"place.":[224],"cognition":[230],"remain":[231],"clinically":[232],"relevant":[233],"least":[236],"2":[237],"years,":[238],"over":[241,245],"projected":[242],"increasing":[244],"time.":[246],"also":[253],"reported":[255],"behavioural":[257],"domains":[258],"104":[267],"Lewy":[274],"body":[275],"variant":[276],"96":[280],"weeks.":[281],"Rivastigmine":[282],"progression,":[286],"allowing":[287],"autonomy":[291],"longer.":[293]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}